Inflammatory Crosstalk Driven by Metabolic and Hemodynamic Stress in Diabetic Nephropathy.

INTRODUCTION: Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus, leading to progressive kidney damage and end-stage renal disease. Its multifactorial pathogenesis involves hemodynamic alterations, metabolic disturbances, oxidative stress, and inflammatory responses. Understanding these mechanisms is essential for developing effective preventive and therapeutic strategies. METHODS: This review synthesizes current literature on the pathophysiology of DN, focusing on structural and functional kidney changes, molecular pathways, and mediators implicated in disease progression. The discussion includes hemodynamic factors such as glomerular hyperfiltration and pressure changes, activation of the renin-angiotensin-aldosterone system (RAAS), and endothelin signaling; metabolic pathways including the polyol pathway, hexosamine pathway, and advanced glycation end products (AGEs); and the role of cytokines, growth factors, oxidative stress, and inflammation. RESULT: Hyperglycemia-induced kidney injury manifests as microalbuminuria, basement membrane thickening, mesangial matrix expansion, and glomerulosclerosis. RAAS activation and vasoconstriction exacerbate hemodynamic stress, while metabolic dysregulation triggers cellular damage and fibrosis. Growth factors such as TGF-β, IGFs, PDGF, VEGF, and CTGF further drive mesangial proliferation and extracellular matrix deposition. Oxidative stress amplifies inflammatory cascades, accelerating renal functional decline. DISCUSSION: Diabetic nephropathy results from a complex interplay of hemodynamic, metabolic, and inflammatory mechanisms. While no cure exists, early detection and aggressive management of hyperglycemia, hypertension, and associated risk factors can significantly slow progression. CONCLUSION: Targeting specific molecular pathways offers promise for future therapeutic development. This review investigates the multi-factorial mechanisms underlying diabetic nephropathy by synthesizing findings from recent studies on hemodynamic, metabolic, oxidative, and inflammatory pathways.